InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the complete record of transactions filed by Klichinsky Michael, Chief Scientific Officer. Officer active across 1 companies, notably Carisma Therapeutics Inc.. Aggregated, 2 disclosures have been logged. Total volume traded: €72k. The latest transaction was filed on 1 October 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
US$36,138165,000 shares@ US$0.219100.0% of flow
Common Stock
SEC:0001104659-25-096740·
€36,138165,000 shares@ €0.21950.0% of flow
Common Stock
SEC:0001104659-25-096740:0·
2 of 2 declarations
About Klichinsky Michael
Michael Klichinsky is the Chief Scientific Officer at Carisma Therapeutics Inc. He is responsible for overseeing the company's scientific and research initiatives, focusing on the development of new therapies. His expertise in biology and clinical research is essential for Carisma's innovation.
